View in EDS PDF Full Text

Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.

Saved in:
Bibliographic Details
Title: Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.
Authors: Shameer K; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States., Zhang Y; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States., Jackson D; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom., Rhodes K; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom., Neelufer IKA; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development, AstraZeneca, Macclesfield, United Kingdom., Nampally S; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States., Prokop A; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Warsaw, Poland., Hutchison E; Digital Health, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom., Ye J; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States., Malkov VA; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States., Liu F; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States., Sabin A; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom., Weatherall J; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development, AstraZeneca, Macclesfield, United Kingdom., Duran C; Digital Health, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom., Iacona RB; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States., Khan FM; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States., Mukhopadhyay P; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
Source: Frontiers in oncology [Front Oncol] 2021 Jul 26; Vol. 11, pp. 672916. Date of Electronic Publication: 2021 Jul 26 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34381708
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shameer+K%22">Shameer K</searchLink>; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Jackson+D%22">Jackson D</searchLink>; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rhodes+K%22">Rhodes K</searchLink>; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Neelufer+IKA%22">Neelufer IKA</searchLink>; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development, AstraZeneca, Macclesfield, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Nampally+S%22">Nampally S</searchLink>; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Prokop+A%22">Prokop A</searchLink>; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Hutchison+E%22">Hutchison E</searchLink>; Digital Health, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ye+J%22">Ye J</searchLink>; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Malkov+VA%22">Malkov VA</searchLink>; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Liu+F%22">Liu F</searchLink>; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Sabin+A%22">Sabin A</searchLink>; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Weatherall+J%22">Weatherall J</searchLink>; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development, AstraZeneca, Macclesfield, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Duran+C%22">Duran C</searchLink>; Digital Health, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Iacona+RB%22">Iacona RB</searchLink>; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Khan+FM%22">Khan FM</searchLink>; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Mukhopadhyay+P%22">Mukhopadhyay P</searchLink>; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2021 Jul 26; Vol. 11, pp. 672916. <i>Date of Electronic Publication: </i>2021 Jul 26 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34381708
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2021.672916
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 672916
    Titles:
      – TitleFull: Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shameer K
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Jackson D
      – PersonEntity:
          Name:
            NameFull: Rhodes K
      – PersonEntity:
          Name:
            NameFull: Neelufer IKA
      – PersonEntity:
          Name:
            NameFull: Nampally S
      – PersonEntity:
          Name:
            NameFull: Prokop A
      – PersonEntity:
          Name:
            NameFull: Hutchison E
      – PersonEntity:
          Name:
            NameFull: Ye J
      – PersonEntity:
          Name:
            NameFull: Malkov VA
      – PersonEntity:
          Name:
            NameFull: Liu F
      – PersonEntity:
          Name:
            NameFull: Sabin A
      – PersonEntity:
          Name:
            NameFull: Weatherall J
      – PersonEntity:
          Name:
            NameFull: Duran C
      – PersonEntity:
          Name:
            NameFull: Iacona RB
      – PersonEntity:
          Name:
            NameFull: Khan FM
      – PersonEntity:
          Name:
            NameFull: Mukhopadhyay P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 07
              Text: 2021 Jul 26
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1